New Technologies for Enhancing Health in Older Adults

July 20, 2024 updated by: Agustín Aibar Almazán, University of Jaén

New Technologies for Improving Physical, Mental, and Cognitive Health in Older Adults

New technologies, such as mobile apps, health monitoring devices, interactive video games, and telemedicine platforms, have become invaluable for improving the physical, mental, and cognitive health of older adults. They help maintain flexibility, strengthen muscles, improve balance and posture, alleviate chronic pain, enhance sleep quality, and reduce stress and anxiety. Tools like the Nintendo Wii promote physical activity, improve coordination, and offer social interaction. Overall, these technologies support better mental health, emotional well-being, and independence, contributing to a higher quality of life for older adults.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

76

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Jaén, Spain
        • Agustín Aibar Almazán

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Be 60 years old or older.
  • Present physical autonomy to participate in the technological and physical activities required by the study.
  • Present current affiliation to the social health security system.
  • Sign the informed consent.
  • Understand the instructions, programs and technological protocols of this project.
  • Complete more than 90% of the intervention with technology and exercise.

Exclusion Criteria:

  • Present medical contraindications for performing physical tests or using technologies.
  • Present diseases that limit cognitive performance and physical activity.
  • Present vestibular diseases.
  • Present rheumatological diseases that can be exacerbated by the use of technologies or stress articulate.
  • Refusing to sign the informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control Group
This group will not undergo the physical exercise intervention but will receive general recommendations for comprehensive health care. These include information about the benefits of physical exercise and tips for managing physical and mental health. The control group (CG) will undergo all the proposed physical and mental tests at the beginning of the study and again after 12 weeks. Additionally, during the study period, they will be monitored for changes in physical activity levels, as well as nutritional changes, sleep habits, and stress levels.
Experimental: New Technologies Group
Participants assigned to the experimental group will engage in an exercise program using technologies, including the Nintendo Wii, over a 12-week period, with a frequency of 3 sessions per week, each lasting 45 minutes.

Each session will be divided into three clearly differentiated parts:

i) A 5-minute warm-up consisting of a series of gentle, low-intensity exercises designed to gradually prepare the muscles and joints of older adults for the main exercise. This portion will include flexibility and stretching movements, as well as joint mobility exercises; ii) 35 minutes dedicated to the main section of the intervention using the Nintendo Wii to promote physical, mental, and cognitive activity; iii) 5 minutes for relaxation techniques that incorporate flexibility exercises and stretches.

Each session will be led by a qualified and experienced professional. No incidents of injuries or negative effects were reported during the intervention period. Throughout the 12-week intervention, participants will be periodically followed up by phone to inquire about their physical activity habits.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Balance and gait
Time Frame: Up to twelve weeks
Tinetti. Completion time: 8-10 minutes. While walking behind the patient, the evaluator asks them to respond to the questions from the gait subscale. To answer the balance subscale, the interviewer stands next to the patient. A higher score indicates better functioning. The maximum score for the gait subscale is 12, and for the balance subscale, it is 16. The sum of both scores is used to assess the risk of falls. A higher score indicates a lower risk. A score of less than 19 signifies a high risk of falls.
Up to twelve weeks
Chair sit and reach test
Time Frame: Up to twelve weeks
The test measures low back and hamstring flexibility. Sitting on a chair against a wall, one foot stays flat on the floor. Extend the other leg forward with knee straight, heel down, and ankle bent at 90°. Stack hands with middle fingers aligned. Inhale, then exhale while reaching toward toes without bouncing or pain. Keep back straight and head up, holding the stretch for 2 seconds. Measure distance between fingertips and toes: zero if touching, negative if not touching, positive if overlapping. Record to nearest 1/2 inch or 1 cm, noting which leg was used.
Up to twelve weeks
Back scratch test
Time Frame: Up to twelve weeks
The shoulder range of motion test is conducted standing. Place one hand behind the head and over the shoulder, reaching down the middle of your back with palm touching your body and fingers pointing downwards. The other hand goes behind your back, palm out and fingers up, aiming to touch or overlap the middle fingers of both hands. An assistant aligns fingers and measures the distance between their tips. Score zero if fingertips touch, negative if not touching, positive if overlapping. Perform two practice attempts and two test attempts, stopping if pain occurs. Record the best score to the nearest centimeter or half inch for assessment.
Up to twelve weeks
30 second chair stand test
Time Frame: Up to twelve weeks
Evaluates lower extremity strength. To perform the chair stand test: Use a chair with a 44 cm high seat and no armrests, secured against a wall. Ensure consistency by using the same chair for future tests. Participants should wear comfortable sports or walking shoes. Sit with feet flat on the floor, shoulder-width apart, knees slightly bent over 90 degrees, and heels closer to the chair than knees. Cross arms over chest. Start the stopwatch and instruct the participant to stand up fully and sit down, counting each cycle as one repetition within 30 seconds. If the 30-second mark aligns mid-action (standing up or sitting down), count it as a full repetition. Participants can rest during the test, but timing continues until 30 seconds elapsed.
Up to twelve weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 5, 2024

Primary Completion (Actual)

April 5, 2024

Study Completion (Actual)

April 12, 2024

Study Registration Dates

First Submitted

July 15, 2024

First Submitted That Met QC Criteria

July 15, 2024

First Posted (Actual)

July 19, 2024

Study Record Updates

Last Update Posted (Actual)

July 23, 2024

Last Update Submitted That Met QC Criteria

July 20, 2024

Last Verified

July 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • UJA.

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Older People

Clinical Trials on Experimental Group

Subscribe